Grifols Announces Completion Of Follow-Up For All 345 Patients In Phase 3 SPARTA Trial Of Prolastin-C In Alpha-1 Emphysema; Topline Data Expected By End Of 2026

Benzinga Newsdesk www.benzinga.com Positive 62.9%

Neg 0% Neu 0% Pos 62.9%

Comments

No comments yet. Be the first!